The versatility found throughout the EnCor breast biopsy product line extends into the MRI arena by offering grid and pillar/post compatibility in the same EnCor MRI product.
The StarchMark Biopsy Site Marker is the only breast biopsy marker to use polysaccharide (starch) pellets to help manage and control bleeding. Pellets are essentially resorbed in approximately 2 weeks, which includes a stainless steel wireform in the center pellet for long-term radiographic marking of the biopsy site.
September 14, 2023 — Insight Medbotics, a medical device company combining the accuracy of MRI with the precision of ...
September 14, 2023 
May 11, 2023 — According to an accepted manuscript published in ARRS’ own American Journal of Roentgenology (AJR) ...
May 11, 2023 
September 9, 2022 — According to ARRS’ American Journal of Roentgenology (AJR), ultrasound color Doppler twinkling may ...
September 08, 2022 
March 4, 2022 — The WTA and Hologic today jointly announced a landmark partnership introducing Hologic as the global ...
March 04, 2022 
July 7, 2021 — GE Healthcare announced the installation of Serena Bright in five hospitals and radiology centers around ...
July 07, 2021 
October 26, 2020 — iCAD, Inc. announced the Company will showcase the expanded platform for the Xoft Axxent Electronic ...
October 26, 2020 
September 8, 2020 — Advanced Radiation Therapy has completed the installation of the AccuBoost Digital platform at the ...
September 08, 2020 
August 28, 2020 — Hologic, Inc., an innovative medical technology company primarily focused on improving women’s health ...
August 28, 2020 
November 26, 2019 — Unifi Workspace, a new comprehensive breast diagnostic reading solution from Hologic, will launch at ...
November 26, 2019 
The current body of research supporting digital breast tomosynthesis (DBT or 3-D mammography) is now overwhelming, with ...
October 17, 2019